Biocon Limited has successfully completed the buyback of its Commercial Papers (CPs) worth ₹600 Crores. The buyback and payment obligations were fulfilled as of September 19, 2025. The CPs were issued for purposes already disclosed, and the company remains compliant with all listing conditions. The buyback is in accordance with SEBI guidelines.
Commercial Paper Buyback Completion
Biocon Limited announced the successful completion of the buyback of its Commercial Papers (CPs) amounting to ₹600 Crores. The buyback was finalized on September 19, 2025, with all payment obligations fulfilled.
Key Details of the Buyback
The following table highlights the key details regarding the commercial paper buyback:
| ISIN | Buyback Date | Date of Payment |
|---|---|---|
| INE376G14032 | September 19, 2025 | September 19, 2025 |
Compliance and Declarations
The company confirms that the CPs were issued for the purposes previously disclosed and that the proceeds were utilized accordingly. Biocon Limited adheres to all listing conditions as stipulated in the application for listing. Furthermore, all other conditions of the offer document and CP issuance directions have been adhered to.
Financial Status
The asset classification of fund-based facilities from banks/Financial Institutions continues to be classified as “Standard.” The company confirms that there has been no material change in its financial status that would adversely affect the credit rating of the CPs.
CP Issuance Details
The Commercial Papers were initially issued to refinance existing borrowings. Key details include:
| Issuer Name | Date of Issue of CP | ISIN No. | Units | End Use of Funds |
|---|---|---|---|---|
| Biocon Limited | 22/04/2025 | INE376G14032 | 12,000 | Refinance existing borrowings |
Source: BSE
